IntroductionDown syndrome (DS) is associated with elevated risk for Alzheimer's disease (AD) due to amyloid beta (Aβ) lifelong accumulation. We hypothesized that the spatial distribution of brain Aβ predicts future dementia conversion in individuals with DS.MethodsWe acquired 18F-florbetapir positron emission tomography scans from 19 nondemented individuals with DS at baseline and monitored them for 4 years, with five individuals transitioning to dementia. Machine learning classification using an independent test set determined features on 18F-florbetapir standardized uptake value ratio maps that predicted transition.ResultsIn addition to "AD signature" regions including the inferior parietal cortex, temporal lobes, and the cingulum, we fou...
Objective: To investigate brain β-amyloid binding in subjects with Down syndrome (DS) using [18F] fl...
Down syndrome (DS) results in an overproduction of amyloid-β (Aβ) peptide associated with early onse...
ObjectiveAdults with Down syndrome (DS) develop Alzheimer disease (AD) pathology by their 5th decade...
IntroductionDown syndrome (DS) is associated with elevated risk for Alzheimer's disease (AD) due to ...
Older adults with Down syndrome (DS) often have Alzheimer's disease (AD) neuropathologies. Although ...
Introduction Adults with Down syndrome (DS) invariably develop Alzheimer's disease (AD) neuropatholo...
Individuals with Down syndrome (DS) are more likely to experience earlier onset of multiple facets o...
Individuals with Down syndrome (DS) are more likely to experience earlier onset of multiple facets o...
Introduction: Comorbid Alzheimer disease pathologies are frequently found in people with Down syndro...
INTRODUCTION: Adults with Down syndrome (DS) invariably develop Alzheimer's disease (AD) neuropathol...
AbstractIntroductionDown Syndrome (DS) adults experience accumulation of Alzheimer's disease (AD)–li...
Individuals with Down Syndrome (DS) are more likely to experience earlier onset of multiple facets o...
IntroductionDown Syndrome (DS) adults experience accumulation of Alzheimer's disease (AD)-like amylo...
Background: We longitudinally assessed Down syndrome individuals at the age of risk of developing de...
People with Down syndrome (DS) develop Alzheimer's disease (AD) at higher rates and a younger age of...
Objective: To investigate brain β-amyloid binding in subjects with Down syndrome (DS) using [18F] fl...
Down syndrome (DS) results in an overproduction of amyloid-β (Aβ) peptide associated with early onse...
ObjectiveAdults with Down syndrome (DS) develop Alzheimer disease (AD) pathology by their 5th decade...
IntroductionDown syndrome (DS) is associated with elevated risk for Alzheimer's disease (AD) due to ...
Older adults with Down syndrome (DS) often have Alzheimer's disease (AD) neuropathologies. Although ...
Introduction Adults with Down syndrome (DS) invariably develop Alzheimer's disease (AD) neuropatholo...
Individuals with Down syndrome (DS) are more likely to experience earlier onset of multiple facets o...
Individuals with Down syndrome (DS) are more likely to experience earlier onset of multiple facets o...
Introduction: Comorbid Alzheimer disease pathologies are frequently found in people with Down syndro...
INTRODUCTION: Adults with Down syndrome (DS) invariably develop Alzheimer's disease (AD) neuropathol...
AbstractIntroductionDown Syndrome (DS) adults experience accumulation of Alzheimer's disease (AD)–li...
Individuals with Down Syndrome (DS) are more likely to experience earlier onset of multiple facets o...
IntroductionDown Syndrome (DS) adults experience accumulation of Alzheimer's disease (AD)-like amylo...
Background: We longitudinally assessed Down syndrome individuals at the age of risk of developing de...
People with Down syndrome (DS) develop Alzheimer's disease (AD) at higher rates and a younger age of...
Objective: To investigate brain β-amyloid binding in subjects with Down syndrome (DS) using [18F] fl...
Down syndrome (DS) results in an overproduction of amyloid-β (Aβ) peptide associated with early onse...
ObjectiveAdults with Down syndrome (DS) develop Alzheimer disease (AD) pathology by their 5th decade...